3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
34
Lung Neoplasms
9
Small Cell Lung Carcinoma
8
Pancreatic Neoplasms
7
Prostatic Neoplasms
5
Ovarian Neoplasms
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Breast Neoplasms
4
Sarcoma
3
Melanoma
3
Carcinoma, Renal Cell
3
Carcinoma
3
Thyroid Neoplasms
2
Neoplasms
2
Chondrosarcoma
2
Cholangiocarcinoma
2
Carcinoma, Medullary
2
Carcinoma, Hepatocellular
2
Adenocarcinoma of Lung
2
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Squamous Non-Small Cell Lung Cancer
1
Sarcoma, Synovial
1
Rhabdoid Tumor
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Recurrence
1
Interventions
osimertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
EGFR T790M Mutation Positive NSCLC
×
Thoracic
×
Clear all
NCT02451852
2016-07-14
AZD9291 US Expanded Access Program
AstraZeneca
No longer available